New Version of CRISPR Edits RNA to Correct Mutations Without Impacting Genome

New Version of CRISPR Edits RNA to Correct Mutations Without Impacting Genome
MIT researchers have developed REPAIR, a new version of the CRISPR/Cas9 gene editing system that can edit RNA instead of DNA — so as not to alter a person’s genome — and may one day be used to treat Parkinson’s and a variety of other diseases. The findings are published in the study, “RNA editing with CRISPR-Cas13,” in the journal ... read more
Source: Parkinson’s News TodayPublished on 2017-11-02By Iqra Mumal